Michael J. DiStefano

1.2k total citations · 1 hit paper
35 papers, 802 citations indexed

About

Michael J. DiStefano is a scholar working on Economics and Econometrics, General Health Professions and Orthopedics and Sports Medicine. According to data from OpenAlex, Michael J. DiStefano has authored 35 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 9 papers in General Health Professions and 8 papers in Orthopedics and Sports Medicine. Recurrent topics in Michael J. DiStefano's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (9 papers) and Sports injuries and prevention (8 papers). Michael J. DiStefano is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (9 papers) and Sports injuries and prevention (8 papers). Michael J. DiStefano collaborates with scholars based in United States, Hungary and South Africa. Michael J. DiStefano's co-authors include Stephen W. Marshall, Darin A. Padua, Lindsay J. DiStefano, Anthony I. Beutler, Sarah J. de la Motte, Harald Schmidt, Gerard F. Anderson, Sakiko Oyama, Kristen L. Kucera and David R. Bell and has published in prestigious journals such as JAMA, Medicine & Science in Sports & Exercise and The American Journal of Sports Medicine.

In The Last Decade

Michael J. DiStefano

33 papers receiving 751 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Landing Error Scoring System as a Screening Tool for an Anterior Cruciate Ligament Injury–Prevention Program in Elite-Youth Soccer Athletes

2015 294 citations Darin A. Padua, Lindsay J. DiStefano et al. Journal of Athletic Training profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. DiStefano United States	11	560	384	195	89	84	35	802
Mark Roe Ireland	14	577 1.0×	109 0.3×	67 0.3×	150 1.7×	37 0.4×	36	792
Heidi Y. Yang United States	16	138 0.2×	426 1.1×	66 0.3×	172 1.9×	34 0.4×	35	739
Christian J. Barton Australia	14	202 0.4×	223 0.6×	136 0.7×	219 2.5×	16 0.2×	56	780
Margaret Harrison Canada	10	96 0.2×	235 0.6×	111 0.6×	78 0.9×	43 0.5×	15	527
David G. Deckey United States	15	89 0.2×	549 1.4×	55 0.3×	50 0.6×	41 0.5×	75	749
Sanaz Hariri United States	12	78 0.1×	449 1.2×	86 0.4×	64 0.7×	37 0.4×	27	611
Ole Tjomsland Norway	13	137 0.2×	292 0.8×	65 0.3×	79 0.9×	39 0.5×	34	599
Erin Cassell Australia	14	219 0.4×	104 0.3×	34 0.2×	285 3.2×	8 0.1×	38	607
Gino De Angelis Canada	15	52 0.1×	130 0.3×	56 0.3×	149 1.7×	92 1.1×	23	628
Katharina Pils Austria	11	85 0.2×	125 0.3×	34 0.2×	46 0.5×	17 0.2×	34	396

Countries citing papers authored by Michael J. DiStefano

Since Specialization

Citations

This map shows the geographic impact of Michael J. DiStefano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. DiStefano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. DiStefano more than expected).

Fields of papers citing papers by Michael J. DiStefano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. DiStefano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. DiStefano. The network helps show where Michael J. DiStefano may publish in the future.

Co-authorship network of co-authors of Michael J. DiStefano

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. DiStefano. A scholar is included among the top collaborators of Michael J. DiStefano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. DiStefano. Michael J. DiStefano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zemplényi, Antal, Jim Leonard, Michael J. DiStefano, et al.. (2025). Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI’s Gene Therapy Access Model. PharmacoEconomics. 43(5). 583–594. 3 indexed citations

DiStefano, Michael J., et al.. (2024). The Cost of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes Pregnancies in the United States: A Cost-Consequences Analysis Using Real-World Evidence. Diabetes Technology & Therapeutics. 27(4). 329–333. 2 indexed citations

DiStefano, Michael J., et al.. (2024). An empirical ethics study of the coherence of NICE technology appraisal policy and its implications for moral justification. BMC Medical Ethics. 25(1). 28–28. 1 indexed citations

DiStefano, Michael J., et al.. (2024). The ethical canary: narrow reflective equilibrium as a source of moral justification in healthcare priority-setting. Journal of Medical Ethics. 50(12). 835–840. 1 indexed citations

DiStefano, Michael J., Antal Zemplényi, & R. Brett McQueen. (2024). Assessing clinical benefit in the Medicare Drug Price Negotiation Program: A 2-step approach for improving transparency, consistency, and meaningful patient engagement. Journal of Managed Care & Specialty Pharmacy. 30(3). 252–258. 2 indexed citations

DiStefano, Michael J., et al.. (2023). Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance. JAMA Health Forum. 4(5). e231090–e231090. 8 indexed citations

Crane, Matthew A., Michael J. DiStefano, & Thomas J. Moore. (2023). False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland. JAMA Network Open. 6(11). e2342210–e2342210. 4 indexed citations

DiStefano, Michael J., Safura Abdool Karim, Carleigh Krubiner, & Karen Hofman. (2023). Integrating Health Technology Assessment and the Right to Health in South Africa: A Qualitative Content Analysis of Substantive Values in Landmark Judicial Decisions. The Journal of Law Medicine & Ethics. 51(1). 131–149.

DiStefano, Michael J., et al.. (2023). Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations. Value in Health. 26(11). 1618–1624. 4 indexed citations

10.

DiStefano, Michael J., et al.. (2023). Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation program. Expert Review of Pharmacoeconomics & Outcomes Research. 24(2). 171–180. 1 indexed citations

11.

Krubiner, Carleigh, Aviva Tugendhaft, Michael J. DiStefano, et al.. (2022). The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa. Value in Health Regional Issues. 34. 23–30. 7 indexed citations

12.

DiStefano, Michael J., G. Caleb Alexander, Daniel Polsky, & Gerard F. Anderson. (2022). Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey. Journal of the American Geriatrics Society. 70(6). 1685–1694. 9 indexed citations

13.

DiStefano, Michael J., et al.. (2021). Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs. Value in Health. 24(3). 397–403. 5 indexed citations

14.

DiStefano, Michael J. & Carleigh Krubiner. (2020). Beyond the numbers: a critique of quantitative multi-criteria decision analysis. International Journal of Technology Assessment in Health Care. 36(4). 292–296. 12 indexed citations

15.

Ali, Joseph, Michael J. DiStefano, Dustin G. Gibson, et al.. (2019). Ethics of mobile phone surveys to monitor non-communicable disease risk factors in low- and middle-income countries: A global stakeholder survey. Global Public Health. 14(8). 1167–1181. 12 indexed citations

16.

DiStefano, Michael J., et al.. (2019). Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries. Health Affairs. 38(5). 804–811. 20 indexed citations

17.

DiStefano, Michael J. & Harald Schmidt. (2016). mHealth for Tuberculosis Treatment Adherence: A Framework to Guide Ethical Planning, Implementation, and Evaluation. Global Health Science and Practice. 4(2). 211–221. 41 indexed citations

18.

Padua, Darin A., Lindsay J. DiStefano, Anthony I. Beutler, et al.. (2015). The Landing Error Scoring System as a Screening Tool for an Anterior Cruciate Ligament Injury–Prevention Program in Elite-Youth Soccer Athletes. Journal of Athletic Training. 50(6). 589–595. 294 indexed citations breakdown →

19.

DiStefano, Lindsay J., Michael J. DiStefano, Barnett S. Frank, Micheal A. Clark, & Darin A. Padua. (2013). Comparison of Integrated and Isolated Training on Performance Measures and Neuromuscular Control. The Journal of Strength and Conditioning Research. 27(4). 1083–1090. 48 indexed citations

20.

DiStefano, Lindsay J., Darin A. Padua, Michael J. DiStefano, & Stephen W. Marshall. (2009). Influence of Age, Sex, Technique, and Exercise Program on Movement Patterns after an Anterior Cruciate Ligament Injury Prevention Program in Youth Soccer Players. The American Journal of Sports Medicine. 37(3). 495–505. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact